Arrayjet Celebrates Further North American Sales Success
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Arrayjet has announced that it had successfully installed a further four instruments in key microarray labs across North America during the past 12 months.
The instruments in question, all Marathon or Super-Marathon Inkjet Microarrayers, were installed in prestigious laboratories: UHN Microarray Centre (Toronto), USAMRIID (Frederick, MD), Cornell University (Ithaca, NYS) and a large Bay Area biotechnology company.
Arrayjet’s Commercial Director, Duncan Hall, commented on this excellent show of confidence in the Arrayjet platform, “Our customers are all leading microarray scientists, who have a clear idea of their wants and needs. We have undergone extensive proving of our platform to these scientists in order to demonstrate that Arrayjet instruments really are the best choice for serious, leading-edge laboratories like theirs. Furthermore, we continue to enjoy high levels of interest from North American microarray groups, and are confident of further success in that market”.
Hall continued, “We strive to get the very best from our microarray platform, and have implemented a series of further improvements to bring additional benefits to both new and existing users of our technology. I think this continuing program of improvements and enhancements differentiates us from our competition, many of whom are still selling machines which reached the pinnacle of their development almost a decade ago.”
The instruments in question, all Marathon or Super-Marathon Inkjet Microarrayers, were installed in prestigious laboratories: UHN Microarray Centre (Toronto), USAMRIID (Frederick, MD), Cornell University (Ithaca, NYS) and a large Bay Area biotechnology company.
Arrayjet’s Commercial Director, Duncan Hall, commented on this excellent show of confidence in the Arrayjet platform, “Our customers are all leading microarray scientists, who have a clear idea of their wants and needs. We have undergone extensive proving of our platform to these scientists in order to demonstrate that Arrayjet instruments really are the best choice for serious, leading-edge laboratories like theirs. Furthermore, we continue to enjoy high levels of interest from North American microarray groups, and are confident of further success in that market”.
Hall continued, “We strive to get the very best from our microarray platform, and have implemented a series of further improvements to bring additional benefits to both new and existing users of our technology. I think this continuing program of improvements and enhancements differentiates us from our competition, many of whom are still selling machines which reached the pinnacle of their development almost a decade ago.”
